Takeda

Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda
Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda
Endpoints
Samsung Bioepis
Takeda
drug development
TAK-671
pancreatitis
Flag link:
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Why Has 2017 Been a Horrible Year So Far for Biotech Acquisitions?
Motley Fool
biotech
M&A
JNJ
Actelion
Takeda
Ariad Pharmaceuticals
Gilead Sciences
Pfizer
Amgen
Flag link:
Takeda partners to develop novel oncology therapies
Takeda partners to develop novel oncology therapies
Drug Delivery Business News
Takeda
Molecular Templates
Millenium
oncology
drug development
Flag link:
Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula
Tesaro partners with Takeda in Asia, bagging a $340M deal for Zejula
Endpoints
Tesaro
Takeda
Japan
Zejula
Flag link:
Takeda, BioSurfaces collab on GI drug-delivery devices
Takeda, BioSurfaces collab on GI drug-delivery devices
Drug Delivery Business News
Takeda
BioSurfaces
GI disease
drug delivery
R&D
Flag link:
Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report
Takeda relocates hundreds of R&D, vaccine staffers and cuts 480 in sales: report
Fierce Pharma
Takeda
R&D
drug reps
layoffs
reorganization
vaccines
Boston
Flag link:
With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022
With appeals court win, Takeda scores blockbuster Velcade patent reprieve till 2022
Fierce Pharma
Takeda
Velcade
patents
generics
Flag link:
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Amgen's battered Kyprolis nabs a survival win, slashing death risk in Revlimid-chemo combo
Fierce Pharma
Amgen
Kyprolis
Revlimid
Celgene
Takeda
Velcade
Multiple Myeloma
Flag link:
With patent loss looming, Takeda knocks proposed Velcade copycats in FDA petition
With patent loss looming, Takeda knocks proposed Velcade copycats in FDA petition
Fierce Pharma
patents
Takeda
Velcade
FDA
exclusivity
Flag link:
Seattle Genetics Drug Scratches Out Win In Hodgkin Lymphoma
Seattle Genetics Drug Scratches Out Win In Hodgkin Lymphoma
Forbes
Seattle Genetics
Takeda
Hodgkin's lymphoma
Adcetris
Flag link:
Takeda set to open new German manufacturing facilities
Takeda set to open new German manufacturing facilities
BioPharma Dive
Takeda
Germany
Europe
drug manufacturing
Flag link:
Takeda starts work on €40M plant to produce multiple myeloma drug Ninlaro
Takeda starts work on €40M plant to produce multiple myeloma drug Ninlaro
Fierce Pharma
Takeda
drug manufacturing
Multiple Myeloma
Ninlaro
Flag link:
Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer
Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer
Fierce Pharma
Takeda
Roche
ALK inhibitors
ASCO 2017
lung cancer
Flag link:
AbbVie, Novo Nordisk and Takeda Have the Best Reputations Among Pharma Companies According to Reputation Institute Global Pharma Reptrak® Study
AbbVie, Novo Nordisk and Takeda Have the Best Reputations Among Pharma Companies According to Reputation Institute Global Pharma Reptrak® Study
PR Web
reputation
AbbVie
Novo Nordisk
Takeda
Flag link:
Takeda pens GammaDelta Therapeutics $100M pact, with M&A option
Takeda pens GammaDelta Therapeutics $100M pact, with M&A option
Fierce Biotech
Takeda
GammaDelta Therapeutics
M&A
R&D
gamma delta T cells
Flag link:
Takeda's Ariad deal pays off with blockbuster green light for Alunbrig
Takeda's Ariad deal pays off with blockbuster green light for Alunbrig
Fierce Pharma
Takeda
Ariad Pharmaceuticals
Alunbrig
ALK-positive non-small cell lung cancer
Flag link:
J&J, Takeda among interested in Brazil's Hypermarcas, sources say
J&J, Takeda among interested in Brazil's Hypermarcas, sources say
Yahoo/Reuters
JNJ
Takeda
Hypermarcas
Brazil
M&A
Novartis
Flag link:
About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet
About that pharma M&A comeback? Sorry. 2017's not bringing it—at least not yet
Fierce Pharma
M&A
Stada
Shire
Baxalta
JNJ
Actelion
Mylan Labs
Pfizer
Takeda
Ariad Pharmaceuticals
Medivation
Flag link:
Takeda continues global R&D reboot with a new joint venture with PRA
Takeda continues global R&D reboot with a new joint venture with PRA
Endpoints
Takeda
R&D
CROs
PRA
Flag link:
Takeda chops into Ariad staff, handing out about 180 pink slips as it revamps Boston ops
Takeda chops into Ariad staff, handing out about 180 pink slips as it revamps Boston ops
Endpoints
Takeda
layoffs
Ariad Pharmaceuticals
reorganization
Flag link: